Fennec announces common shares offering, no amount given

Fennec (FENC) Pharmaceuticals announced that it intends to offer and sell its common shares in an underwritten registered public offering. Fennec intends to use the net proceeds of the proposed offering to repurchase and redeem certain indebtedness and the remaining net proceeds, if any, for working capital and general corporate purposes. Piper Sandler & Co. and Craig-Hallum Capital Group are acting as the joint book-running managers for the proposed public offering.